Published in BMC Infect Dis on November 17, 2010
Enteric protozoa in the developed world: a public health perspective. Clin Microbiol Rev (2012) 1.52
Brucellosis in low-income and middle-income countries. Curr Opin Infect Dis (2013) 1.20
Spectrum of Imported Infectious Diseases: A Comparative Prevalence Study of 16,817 German Travelers and 977 Immigrants from the Tropics and Subtropics. Am J Trop Med Hyg (2016) 1.13
Epidemiology of imported malaria in the mediterranean region. Mediterr J Hematol Infect Dis (2012) 1.03
Globalization of leptospirosis through travel and migration. Global Health (2014) 1.02
Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting. BMC Genomics (2014) 0.88
Complementary exams in the diagnosis of American tegumentary leishmaniasis. An Bras Dermatol (2014) 0.85
The Avalanche is Coming … And Just Now It's Starting to Snow. Front Immunol (2013) 0.82
Morbidity of foreign travelers in Attica, Greece: a retrospective study. Eur J Clin Microbiol Infect Dis (2012) 0.82
Social and Economic Burden of Human Leishmaniasis. Am J Trop Med Hyg (2016) 0.82
Risk for travel-associated legionnaires' disease, Europe, 2009. Emerg Infect Dis (2012) 0.78
Brucella melitensis prosthetic joint infection in a traveller returning to the UK from Thailand: Case report and review of the literature. Travel Med Infect Dis (2016) 0.77
Imported malaria in Belgrade, Serbia, between 2001 and 2009. Wien Klin Wochenschr (2011) 0.77
Chagasic patients are able to respond against a viral antigen from influenza virus. BMC Infect Dis (2012) 0.76
The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study. Eur J Clin Nutr (2014) 0.75
Morbidity and outcomes of foreign travelers in Zakynthos island, Greece: a retrospective study. PLoS One (2014) 0.75
A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure. BMC Infect Dis (2017) 0.75
Leprosy in England and Wales 1953-2012: surveillance and challenges in low incidence countries. BMJ Open (2016) 0.75
Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet (2007) 10.81
Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med (2006) 8.72
Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis (2007) 3.53
Aedes albopictus, an arbovirus vector: from the darkness to the light. Microbes Infect (2009) 3.25
Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop (2009) 3.22
Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am (2008) 1.69
Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion (2008) 1.64
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. Emerg Infect Dis (2009) 1.61
Tick-borne encephalitis in Europe and beyond--the epidemiological situation as of 2007. Euro Surveill (2008) 1.47
Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance Network. Vaccine (2007) 1.45
Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev (2008) 1.39
Swine flu goes global. Nature (2009) 1.35
Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis (2009) 1.19
Imported malaria in children in industrialized countries, 1992-2002. Emerg Infect Dis (2009) 1.15
Introduction of SARS in France, March-April, 2003. Emerg Infect Dis (2004) 1.10
Trends in the epidemiology of dengue fever and their relevance for importation to Europe. Euro Surveill (2009) 1.08
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int J Infect Dis (2008) 1.02
A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers. J Infect (2009) 1.00
Chikungunya infection confirmed in a Belgian traveller returning from Phuket (Thailand). Euro Surveill (2009) 0.93
The risk of malaria in travelers to India. J Travel Med (2009) 0.92
Influenza vaccine: a travelers' vaccine? Expert Rev Vaccines (2008) 0.92
Chagas disease travels to Europe. Lancet (2009) 0.87
Diphtheria surveillance and control in the Former Soviet Union and the Newly Independent States. J Infect Dis (2000) 0.87
Variability in malaria prophylaxis prescribing across Europe: a Delphi method analysis. J Travel Med (2008) 0.86
Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas. Travel Med Infect Dis (2008) 0.82
Rabies preexposure vaccination in travelers. J Travel Med (2007) 0.79
The Stop TB Partnership for Europe: aims and principles. Euro Surveill (2007) 0.78
The practice of travel medicine in Europe. Clin Microbiol Infect (2010) 0.78
Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. MMWR Morb Mortal Wkly Rep (2009) 0.78
Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med (2006) 8.72
Scrub typhus and tropical rickettsioses. Curr Opin Infect Dis (2003) 4.28
Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis (2006) 3.87
Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis (2006) 3.69
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet (2004) 3.59
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr (2002) 3.55
Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis (2007) 3.53
GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med (2013) 3.37
Causes of non-malarial fever in Laos: a prospective study. Lancet Glob Health (2013) 3.20
Options for field diagnosis of human african trypanosomiasis. Clin Microbiol Rev (2005) 3.12
Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis (2007) 2.92
Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial. Clin Infect Dis (2013) 2.80
Travel-associated sexually transmitted infections: an observational cross-sectional study of the GeoSentinel surveillance database. Lancet Infect Dis (2012) 2.78
Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med (2002) 2.73
Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) (2007) 2.48
Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med (2004) 2.44
Impact of snake bites and determinants of fatal outcomes in southeastern Nepal. Am J Trop Med Hyg (2004) 2.42
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am J Trop Med Hyg (2006) 2.34
Urbanisation and infectious diseases in a globalised world. Lancet Infect Dis (2011) 2.30
Fleas and flea-borne diseases. Int J Infect Dis (2010) 2.14
Subcutaneous infection with Dirofilaria immitis nematode in human, France. Emerg Infect Dis (2013) 2.10
Imported Chikungunya Infection, Italy. Emerg Infect Dis (2007) 2.08
Travel-related leptospirosis: a series of 15 imported cases. J Travel Med (2013) 2.01
Global perspectives for prevention of infectious diseases associated with mass gatherings. Lancet Infect Dis (2012) 1.99
Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis (2011) 1.98
First molecular detection of Rickettsia felis in fleas from Algeria. Am J Trop Med Hyg (2006) 1.94
Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother (2005) 1.92
Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study. Am J Trop Med Hyg (2008) 1.83
Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis (2014) 1.80
Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort. Arch Intern Med (2012) 1.77
Analysis of the Rickettsia africae genome reveals that virulence acquisition in Rickettsia species may be explained by genome reduction. BMC Genomics (2009) 1.74
Acute respiratory distress syndrome in Plasmodium vivax malaria in traveler returning from Venezuela. J Travel Med (2006) 1.71
Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J Agric Food Chem (2007) 1.71
Sandfly fever due to Toscana virus: an emerging infection in southern France. Eur J Intern Med (2004) 1.70
Chikungunya infection in travelers. Emerg Infect Dis (2006) 1.70
Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am (2008) 1.69
Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol (2005) 1.67
Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis (2009) 1.64
Language barriers between nurses and asylum seekers: their impact on symptom reporting and referral. Soc Sci Med (2003) 1.64
Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis (2002) 1.64
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis (2008) 1.64
Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis (2009) 1.63
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. Emerg Infect Dis (2009) 1.61
Management of imported malaria in Europe. Malar J (2012) 1.60
Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut (2006) 1.60
The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. - a literature review. Travel Med Infect Dis (2013) 1.57
Cutaneous leishmaniasis treatment. Travel Med Infect Dis (2006) 1.56
Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy. J Travel Med (2014) 1.54
Common epidemiology of Rickettsia felis infection and malaria, Africa. Emerg Infect Dis (2013) 1.54
Syphilitic uveitis in patients infected with human immunodeficiency virus. Graefes Arch Clin Exp Ophthalmol (2005) 1.51
Cocirculation of 2 genotypes of Toscana virus, southeastern France. Emerg Infect Dis (2007) 1.50
Massilia virus, a novel Phlebovirus (Bunyaviridae) isolated from sandflies in the Mediterranean. Vector Borne Zoonotic Dis (2009) 1.50
Improving communication between physicians and patients who speak a foreign language. Br J Gen Pract (2003) 1.50
Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J Antimicrob Chemother (2005) 1.50
Expert opinion on vaccination of travelers against Japanese encephalitis. J Travel Med (2009) 1.49
Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. Trop Med Int Health (2009) 1.48
Travel case scenarios as a demonstration of risk assessment of VFR travelers: introduction to criteria and evidence-based definition and framework. J Travel Med (2010) 1.47
Hookworm-related cutaneous larva migrans. J Travel Med (2007) 1.46
Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy. Clin Infect Dis (2009) 1.46
Toscana virus RNA in Sergentomyia minuta files. Emerg Infect Dis (2006) 1.45
Local and International Implications of Schistosomiasis Acquired in Corsica, France. Emerg Infect Dis (2015) 1.45
The visiting friends or relatives traveler in the 21st century: time for a new definition. J Travel Med (2010) 1.45
Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance Network. Vaccine (2007) 1.45
Prevention of malaria in long-term travelers. JAMA (2006) 1.44
Prevention of imported pediatric malaria--travel medicine misses the bull's eye. J Travel Med (2011) 1.43
Kinetics of antibody responses in Rickettsia africae and Rickettsia conorii infections. Clin Diagn Lab Immunol (2002) 1.42
Seroepidemiology of dengue in travellers: a paired sera analysis. Travel Med Infect Dis (2013) 1.42
Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis (2010) 1.42
Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea. J Travel Med (2005) 1.40
Contribution of nonspecific laboratory test to the diagnosis of malaria in febrile travelers returning from endemic areas: value of hypocholesterolemia. J Travel Med (2002) 1.40
Rabies vaccination in travelers: a global perspective. J Travel Med (2012) 1.38
Viruses acquired abroad: what does the primary care physician need to know? Dtsch Arztebl Int (2012) 1.38
Comment to the editorial: Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons, by Vincent Soriano and Javier García-Samaniego. HIV Clin Trials (2002) 1.37
Genotyping of Orientia tsutsugamushi from humans with scrub typhus, Laos. Emerg Infect Dis (2008) 1.37
Knowledge, attitudes, and practices of French travelers from Marseille regarding rabies risk and prevention. J Travel Med (2009) 1.36
Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study. J Travel Med (2003) 1.36
Chikungunya and dengue autochthonous cases in Europe, 2007-2012. Travel Med Infect Dis (2013) 1.35
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine (2008) 1.35
Epidemiology of relapsing fever borreliosis in Europe. FEMS Immunol Med Microbiol (2006) 1.32
Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline. Antimicrob Agents Chemother (2008) 1.29
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome. J Acquir Immune Defic Syndr (2003) 1.28
Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis. Int Health (2012) 1.28
Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis (2010) 1.27